医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.

广告
第一作者: Anna,Laemmerer
第一单位: Department of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.;Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
作者单位: Department of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.;Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [1] Vienna BioCenter (VBC), PhD Program, Doctoral School of the University of Vienna and Medical University of Vienna, Vienna, Austria.;IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter (VBC), Vienna, Austria. [2] Department of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria. [3] Department of Neurosurgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.;Department of Pediatrics and Adolescent Medicine, Comprehensive Cancer Center and Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria. [4] Department of Neurosurgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.;Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [5] Charles River Laboratories Germany GmbH, Freiburg, Germany. [6] Joint Applied Medicinal Radiochemistry Facility, University of Vienna, Medical University of Vienna, Vienna, Austria.;Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. [7] Center for Cancer Research and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [8] Department of Neurosurgery, Kepler University Hospital GmbH, Johannes Kepler University, Linz, Austria. [9] Division of Neuroradiology and Musculoskeletal Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. [10] Division of Nuclear Medicine, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria. [11] Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria. [12] National Center for Tumor Diseases (NCT), Heidelberg, Germany.;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.;Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. [13] Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria. [14] Department of Neurosurgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. [15] IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter (VBC), Vienna, Austria. [16] Division of Cell and Developmental Biology, Center for Anatomy and Cell Biology, Medical University of Vienna, Vienna, Austria. [17] Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany. [18] Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.;National Center for Tumor Diseases (NCT), Heidelberg, Germany.;Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.;Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. [19] Department of Neurology, Medical University of Vienna, Vienna, Austria.;IMBA - Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna BioCenter (VBC), Vienna, Austria. [20]
DOI 10.1093/neuonc/noae228
PMID 39556024
发布时间 2025-04-26
提交
  • 浏览0
Neuro-oncology

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷